comparemela.com
Home
Live Updates
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application : comparemela.com
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
Related Keywords
United States ,
America ,
Dave Innes ,
Les Goldman ,
Company Securities ,
University Of Pennsylvania ,
Exchange Commission ,
Healthcare Products Regulatory Agency ,
Company Dcvax ,
Marketing Authorization Application ,
Pediatric Investigation Plan ,
North America ,
Private Securities Litigation Reform Act ,
Risk Factors ,
Northwest Biotherapeutics ,
comparemela.com © 2020. All Rights Reserved.